disease-free survival, overall survival, 2-year survival, local control overall and at 2 years, median survival, relapse-free survival, regional control, and freedom from distant metastases.
Contact Info:
Primary Study Contact Person: Cmelak, Anthony[mailto:anthony.cmelak@Vanderbilt.Edu]